PharmaEngine (4162 TWO) stock market data APIs
NT$93.6
0(0%)
as of January 20, 2025
PharmaEngine Financial Data Overview
Price chart is built with
Anychart
PharmaEngine, Inc., a biopharmaceutical company, engages in the development of drugs and therapeutic drugs for treating cancer in Taiwan and Europe. It offers ONIVYDE, a novel and stable encapsulated chemotherapy drug irinotecan for the treatment of metastatic pancreatic cancer and other indications of clinical development. The company is developing PEP07, a checkpoint kinase 1 inhibitor, which is in preclinical development stage for the treatment of hematologic cancers and solid cancers, such as acute myeloid leukemia and mantle cell lymphoma. PharmaEngine, Inc. was incorporated in 2002 and is headquartered in Taipei, Taiwan.
Prev. Close
93.6
Open
93.6
Volume
361 K
High
94.1
Low
92
52 wk Range
73.4862-112.9801
Market Cap
13 391 M
P/E Ratio
36.2646
Shares Outstanding
144 M
Revenue
860 M
EPS
0.64
Dividends (Yield)
0.0146
Beta
0.628
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get PharmaEngine data using free add-ons & libraries
Get PharmaEngine Fundamental Data
PharmaEngine Fundamental data includes:
- Net Revenue: 860 M
- EBITDA: 355 M
- Earnings Per Share: 2
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2024-10-31
- EPS/Forecast: 0.67
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
PharmaEngine News
New
Nanobiotix, PharmaEngine Terminate Development Pact For Radiation Therapy In APAC Region
Nanobiotix (NASDAQ: NBTX) and PharmaEngine Inc have agreed to terminate the license and collaboration agreement announced in August 2012. The agreement provided PharmaEngine exclusive rights to furth...
Nanobiotix, PharmaEngine Terminate Development Pact For Radiation Therapy In APAC Region
Nanobiotix (NASDAQ: NBTX) and PharmaEngine Inc have agreed to terminate the license and collaboration agreement announced in August 2012. The agreement provided PharmaEngine exclusive rights to furth...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
